Ian Critchley Email

VP, Head Clinical Microbiology . Spero Therapeutics

Current Roles

Employees:
64
Revenue:
$17.4M
About
Spero Therapeutics aims to be the premier company developing novel therapies to treat highly resistant bacterial infections. The culture at Spero is one of respect, action, collaboration and transparency. Spero team members are leaders in the field, and have the ability and desire to be a part of a team. At Spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.
Spero Therapeutics Address
675 Massachusetts Ave
Cambridge, MA
United States
Spero Therapeutics Email

Past Companies

Spero TherapeuticsVice President, Head of Clinical Microbiology
AllerganVice President, Clinical Microbiology
PharMicro Consulting, LLC/ Consulting in antibacterial R&D and clinical microbiologyPrincipal

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.